메뉴 건너뛰기




Volumn 21, Issue 3, 2009, Pages 346-351

Heterologous prime-boost vaccination

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTHRAX VACCINE; BCG VACCINE; CANCER VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DNA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INACTIVATED VACCINE; MALARIA VACCINE; ORAL POLIOMYELITIS VACCINE; RECOMBINANT GLYCOPROTEIN GP 120; SUBUNIT VACCINE; VACCINIA VACCINE; VIRUS VECTOR;

EID: 67049086871     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2009.05.016     Document Type: Review
Times cited : (389)

References (39)
  • 1
    • 17144432813 scopus 로고    scopus 로고
    • The prime-boost concept applied to HIV preventive vaccines
    • Excler J.L., and Plotkin S. The prime-boost concept applied to HIV preventive vaccines. Aids 11 Suppl. A (1997) S127-S137
    • (1997) Aids , vol.11 , Issue.SUPPL. A
    • Excler, J.L.1    Plotkin, S.2
  • 2
    • 0034176364 scopus 로고    scopus 로고
    • The prime-boost strategy: exciting prospects for improved vaccination
    • Ramshaw I.A., and Ramsay A.J. The prime-boost strategy: exciting prospects for improved vaccination. Immunol Today 21 (2000) 163-165
    • (2000) Immunol Today , vol.21 , pp. 163-165
    • Ramshaw, I.A.1    Ramsay, A.J.2
  • 3
    • 33751071573 scopus 로고    scopus 로고
    • Combination DNA plus protein HIV vaccines
    • Lu S. Combination DNA plus protein HIV vaccines. Springer Semin Immunopathol 28 (2006) 255-265
    • (2006) Springer Semin Immunopathol , vol.28 , pp. 255-265
    • Lu, S.1
  • 4
    • 0026519706 scopus 로고
    • Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160
    • First major report on the use of heterologous prime-boost vaccination approach, in the context of AIDS vaccine development.
    • Hu S.L., Abrams K., Barber G.N., Moran P., Zarling J.M., Langlois A.J., Kuller L., Morton W.R., and Benveniste R.E. Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science 255 (1992) 456-459. First major report on the use of heterologous prime-boost vaccination approach, in the context of AIDS vaccine development.
    • (1992) Science , vol.255 , pp. 456-459
    • Hu, S.L.1    Abrams, K.2    Barber, G.N.3    Moran, P.4    Zarling, J.M.5    Langlois, A.J.6    Kuller, L.7    Morton, W.R.8    Benveniste, R.E.9
  • 5
    • 0025820906 scopus 로고
    • Neutralizing antibodies against HIV-1 BRU and SF2 isolates generated in mice immunized with recombinant vaccinia virus expressing HIV-1 (BRU) envelope glycoproteins and boosted with homologous gp160
    • Hu S.L., Klaniecki J., Dykers T., Sridhar P., and Travis B.M. Neutralizing antibodies against HIV-1 BRU and SF2 isolates generated in mice immunized with recombinant vaccinia virus expressing HIV-1 (BRU) envelope glycoproteins and boosted with homologous gp160. AIDS Res Hum Retroviruses 7 (1991) 615-620
    • (1991) AIDS Res Hum Retroviruses , vol.7 , pp. 615-620
    • Hu, S.L.1    Klaniecki, J.2    Dykers, T.3    Sridhar, P.4    Travis, B.M.5
  • 8
    • 0020517993 scopus 로고
    • Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides
    • Emini E.A., Jameson B.A., and Wimmer E. Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. Nature 304 (1983) 699-703
    • (1983) Nature , vol.304 , pp. 699-703
    • Emini, E.A.1    Jameson, B.A.2    Wimmer, E.3
  • 9
    • 40549138117 scopus 로고    scopus 로고
    • Current progress of DNA vaccine studies in humans
    • Lu S., Wang S., and Grimes-Serrano J.M. Current progress of DNA vaccine studies in humans. Expert Rev Vaccines 7 (2008) 175-191
    • (2008) Expert Rev Vaccines , vol.7 , pp. 175-191
    • Lu, S.1    Wang, S.2    Grimes-Serrano, J.M.3
  • 10
    • 0030872511 scopus 로고    scopus 로고
    • Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit
    • Barnett S.W., Rajasekar S., Legg H., Doe B., Fuller D.H., Haynes J.R., Walker C.M., and Steimer K.S. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit. Vaccine 15 (1997) 869-873
    • (1997) Vaccine , vol.15 , pp. 869-873
    • Barnett, S.W.1    Rajasekar, S.2    Legg, H.3    Doe, B.4    Fuller, D.H.5    Haynes, J.R.6    Walker, C.M.7    Steimer, K.S.8
  • 11
    • 0031657986 scopus 로고    scopus 로고
    • Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting
    • Richmond J.F., Lu S., Santoro J.C., Weng J., Hu S.L., Montefiori D.C., and Robinson H.L. Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting. J Virol 72 (1998) 9092-9100
    • (1998) J Virol , vol.72 , pp. 9092-9100
    • Richmond, J.F.1    Lu, S.2    Santoro, J.C.3    Weng, J.4    Hu, S.L.5    Montefiori, D.C.6    Robinson, H.L.7
  • 12
    • 21644445378 scopus 로고    scopus 로고
    • Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1
    • Beddows S., Schulke N., Kirschner M., Barnes K., Franti M., Michael E., Ketas T., Sanders R.W., Maddon P.J., Olson W.C., et al. Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1. J Virol 79 (2005) 8812-8827
    • (2005) J Virol , vol.79 , pp. 8812-8827
    • Beddows, S.1    Schulke, N.2    Kirschner, M.3    Barnes, K.4    Franti, M.5    Michael, E.6    Ketas, T.7    Sanders, R.W.8    Maddon, P.J.9    Olson, W.C.10
  • 13
    • 19944393561 scopus 로고    scopus 로고
    • Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1
    • Wang S., Arthos J., Lawrence J.M., Van Ryk D., Mboudjeka I., Shen S., Chou T.H., Montefiori D.C., and Lu S. Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1. J Virol 79 (2005) 7933-7937
    • (2005) J Virol , vol.79 , pp. 7933-7937
    • Wang, S.1    Arthos, J.2    Lawrence, J.M.3    Van Ryk, D.4    Mboudjeka, I.5    Shen, S.6    Chou, T.H.7    Montefiori, D.C.8    Lu, S.9
  • 14
    • 33746651142 scopus 로고    scopus 로고
    • Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E
    • By using DNA prime-protein boost vaccination to deliver polyvalent HIV-1 Env antigens, broadly reactive neutralizing antibodies are elicited in immunized sera in a rabbit model.
    • Wang S., Pal R., Mascola J.R., Chou T.H., Mboudjeka I., Shen S., Liu Q., Whitney S., Keen T., Nair B.C., et al. Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E. Virology 350 (2006) 34-47. By using DNA prime-protein boost vaccination to deliver polyvalent HIV-1 Env antigens, broadly reactive neutralizing antibodies are elicited in immunized sera in a rabbit model.
    • (2006) Virology , vol.350 , pp. 34-47
    • Wang, S.1    Pal, R.2    Mascola, J.R.3    Chou, T.H.4    Mboudjeka, I.5    Shen, S.6    Liu, Q.7    Whitney, S.8    Keen, T.9    Nair, B.C.10
  • 15
    • 33745496632 scopus 로고    scopus 로고
    • Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype
    • Pal R., Kalyanaraman V.S., Nair B.C., Whitney S., Keen T., Hocker L., Hudacik L., Rose N., Mboudjeka I., Shen S., et al. Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype. Virology 348 (2006) 341-353
    • (2006) Virology , vol.348 , pp. 341-353
    • Pal, R.1    Kalyanaraman, V.S.2    Nair, B.C.3    Whitney, S.4    Keen, T.5    Hocker, L.6    Hudacik, L.7    Rose, N.8    Mboudjeka, I.9    Shen, S.10
  • 16
    • 39149109930 scopus 로고    scopus 로고
    • Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers
    • First report of inducing broadly reactive NAb in humans in addition to high-level cell-mediated immune responses using a polyvalent, multi-gene DNA prime-protein boost HIV vaccine.
    • Wang S., Kennedy J.S., West K., Montefiori D.C., Coley S., Lawrence J., Shen S., Green S., Rothman A.L., Ennis F.A., et al. Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers. Vaccine 26 (2008) 1098-1110. First report of inducing broadly reactive NAb in humans in addition to high-level cell-mediated immune responses using a polyvalent, multi-gene DNA prime-protein boost HIV vaccine.
    • (2008) Vaccine , vol.26 , pp. 1098-1110
    • Wang, S.1    Kennedy, J.S.2    West, K.3    Montefiori, D.C.4    Coley, S.5    Lawrence, J.6    Shen, S.7    Green, S.8    Rothman, A.L.9    Ennis, F.A.10
  • 17
    • 45749099294 scopus 로고    scopus 로고
    • Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration
    • When a DNA prime-protein boost HIV vaccine was tested in humans, the DNA priming effect delivered by intramuscular (IM) needle injection was more effective than the intradermal (ID) needle injection in eliciting HIV-1 antigen specific cell-mediated immune responses, which is contrary to the long-held hypothesis that ID route is more immunogenic than IM route for DNA vaccines.
    • Bansal A., Jackson B., West K., Wang S., Lu S., Kennedy J.S., and Goepfert P.A. Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration. J Virol 82 (2008) 6458-6469. When a DNA prime-protein boost HIV vaccine was tested in humans, the DNA priming effect delivered by intramuscular (IM) needle injection was more effective than the intradermal (ID) needle injection in eliciting HIV-1 antigen specific cell-mediated immune responses, which is contrary to the long-held hypothesis that ID route is more immunogenic than IM route for DNA vaccines.
    • (2008) J Virol , vol.82 , pp. 6458-6469
    • Bansal, A.1    Jackson, B.2    West, K.3    Wang, S.4    Lu, S.5    Kennedy, J.S.6    Goepfert, P.A.7
  • 19
    • 0032815843 scopus 로고    scopus 로고
    • Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen
    • Hanke T., Samuel R.V., Blanchard T.J., Neumann V.C., Allen T.M., Boyson J.E., Sharpe S.A., Cook N., Smith G.L., Watkins D.I., et al. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen. J Virol 73 (1999) 7524-7532
    • (1999) J Virol , vol.73 , pp. 7524-7532
    • Hanke, T.1    Samuel, R.V.2    Blanchard, T.J.3    Neumann, V.C.4    Allen, T.M.5    Boyson, J.E.6    Sharpe, S.A.7    Cook, N.8    Smith, G.L.9    Watkins, D.I.10
  • 20
    • 0031772993 scopus 로고    scopus 로고
    • Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus
    • Kent S.J., Zhao A., Best S.J., Chandler J.D., Boyle D.B., and Ramshaw I.A. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J Virol 72 (1998) 10180-10188
    • (1998) J Virol , vol.72 , pp. 10180-10188
    • Kent, S.J.1    Zhao, A.2    Best, S.J.3    Chandler, J.D.4    Boyle, D.B.5    Ramshaw, I.A.6
  • 21
    • 0037122719 scopus 로고    scopus 로고
    • Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
    • •], this is another key study reporting that the use of DNA prime-adeno viral vector boost approach was able to elicit protective immune responses against SHIV in a non-human primate model.
    • •], this is another key study reporting that the use of DNA prime-adeno viral vector boost approach was able to elicit protective immune responses against SHIV in a non-human primate model.
    • (2002) Nature , vol.415 , pp. 331-335
    • Shiver, J.W.1    Fu, T.M.2    Chen, L.3    Casimiro, D.R.4    Davies, M.E.5    Evans, R.K.6    Zhang, Z.Q.7    Simon, A.J.8    Trigona, W.L.9    Dubey, S.A.10
  • 22
    • 0041707861 scopus 로고    scopus 로고
    • Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines
    • Barouch D.H., McKay P.F., Sumida S.M., Santra S., Jackson S.S., Gorgone D.A., Lifton M.A., Chakrabarti B.K., Xu L., Nabel G.J., et al. Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines. J Virol 77 (2003) 8729-8735
    • (2003) J Virol , vol.77 , pp. 8729-8735
    • Barouch, D.H.1    McKay, P.F.2    Sumida, S.M.3    Santra, S.4    Jackson, S.S.5    Gorgone, D.A.6    Lifton, M.A.7    Chakrabarti, B.K.8    Xu, L.9    Nabel, G.J.10
  • 23
    • 23444460831 scopus 로고    scopus 로고
    • Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus
    • Egan M.A., Chong S.Y., Megati S., Montefiori D.C., Rose N.F., Boyer J.D., Sidhu M.K., Quiroz J., Rosati M., Schadeck E.B., et al. Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus. AIDS Res Hum Retroviruses 21 (2005) 629-643
    • (2005) AIDS Res Hum Retroviruses , vol.21 , pp. 629-643
    • Egan, M.A.1    Chong, S.Y.2    Megati, S.3    Montefiori, D.C.4    Rose, N.F.5    Boyer, J.D.6    Sidhu, M.K.7    Quiroz, J.8    Rosati, M.9    Schadeck, E.B.10
  • 24
    • 38749132973 scopus 로고    scopus 로고
    • An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
    • Human study results showed that a DNA prime-pox vector boost HIV vaccine elicited higher level and better quality of cell-mediated immune responses in humans, when compared with a pox vector only HIV vaccine with the same antigens in both vaccines.
    • Harari A., Bart P.A., Stohr W., Tapia G., Garcia M., Medjitna-Rais E., Burnet S., Cellerai C., Erlwein O., Barber T., et al. An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses. J Exp Med 205 (2008) 63-77. Human study results showed that a DNA prime-pox vector boost HIV vaccine elicited higher level and better quality of cell-mediated immune responses in humans, when compared with a pox vector only HIV vaccine with the same antigens in both vaccines.
    • (2008) J Exp Med , vol.205 , pp. 63-77
    • Harari, A.1    Bart, P.A.2    Stohr, W.3    Tapia, G.4    Garcia, M.5    Medjitna-Rais, E.6    Burnet, S.7    Cellerai, C.8    Erlwein, O.9    Barber, T.10
  • 26
    • 33749235904 scopus 로고    scopus 로고
    • A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge
    • Dunachie S.J., Walther M., Epstein J.E., Keating S., Berthoud T., Andrews L., Andersen R.F., Bejon P., Goonetilleke N., Poulton I., et al. A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge. Infect Immun 74 (2006) 5933-5942
    • (2006) Infect Immun , vol.74 , pp. 5933-5942
    • Dunachie, S.J.1    Walther, M.2    Epstein, J.E.3    Keating, S.4    Berthoud, T.5    Andrews, L.6    Andersen, R.F.7    Bejon, P.8    Goonetilleke, N.9    Poulton, I.10
  • 27
    • 56849108004 scopus 로고    scopus 로고
    • rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector
    • Prime-boost approach with a bacterial vector and a viral vector for eliciting cell-mediated immune responses in a non-human primate model.
    • Magalhaes I., Sizemore D.R., Ahmed R.K., Mueller S., Wehlin L., Scanga C., Weichold F., Schirru G., Pau M.G., Goudsmit J., et al. rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector. PLoS ONE 3 (2008) e3790. Prime-boost approach with a bacterial vector and a viral vector for eliciting cell-mediated immune responses in a non-human primate model.
    • (2008) PLoS ONE , vol.3
    • Magalhaes, I.1    Sizemore, D.R.2    Ahmed, R.K.3    Mueller, S.4    Wehlin, L.5    Scanga, C.6    Weichold, F.7    Schirru, G.8    Pau, M.G.9    Goudsmit, J.10
  • 28
    • 33747613795 scopus 로고    scopus 로고
    • A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge
    • Cai H., Yu D.H., Hu X.D., Li S.X., and Zhu Y.X. A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge. DNA Cell Biol 25 (2006) 438-447
    • (2006) DNA Cell Biol , vol.25 , pp. 438-447
    • Cai, H.1    Yu, D.H.2    Hu, X.D.3    Li, S.X.4    Zhu, Y.X.5
  • 29
    • 4143110222 scopus 로고    scopus 로고
    • Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting
    • Wang Q.M., Sun S.H., Hu Z.L., Yin M., Xiao C.J., and Zhang J.C. Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting. Vaccine 22 (2004) 3622-3627
    • (2004) Vaccine , vol.22 , pp. 3622-3627
    • Wang, Q.M.1    Sun, S.H.2    Hu, Z.L.3    Yin, M.4    Xiao, C.J.5    Zhang, J.C.6
  • 30
    • 0032698408 scopus 로고    scopus 로고
    • DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model
    • Sin J.I., Bagarazzi M., Pachuk C., and Weiner D.B. DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model. DNA Cell Biol 18 (1999) 771-779
    • (1999) DNA Cell Biol , vol.18 , pp. 771-779
    • Sin, J.I.1    Bagarazzi, M.2    Pachuk, C.3    Weiner, D.B.4
  • 31
    • 0034783743 scopus 로고    scopus 로고
    • Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine
    • Biswas S., Reddy G.S., Srinivasan V.A., and Rangarajan P.N. Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine. Hum Gene Ther 12 (2001) 1917-1922
    • (2001) Hum Gene Ther , vol.12 , pp. 1917-1922
    • Biswas, S.1    Reddy, G.S.2    Srinivasan, V.A.3    Rangarajan, P.N.4
  • 33
    • 13444288031 scopus 로고    scopus 로고
    • Augmented humoral and cellular immune responses of a hepatitis B DNA vaccine encoding HBsAg by protein boosting
    • Xiao-wen H., Shu-han S., Zhen-lin H., Jun L., Lei J., Feng-juan Z., Ya-nan Z., and Ying-jun G. Augmented humoral and cellular immune responses of a hepatitis B DNA vaccine encoding HBsAg by protein boosting. Vaccine 23 (2005) 1649-1656
    • (2005) Vaccine , vol.23 , pp. 1649-1656
    • Xiao-wen, H.1    Shu-han, S.2    Zhen-lin, H.3    Jun, L.4    Lei, J.5    Feng-juan, Z.6    Ya-nan, Z.7    Ying-jun, G.8
  • 34
    • 45049083212 scopus 로고    scopus 로고
    • Heterologous HA DNA vaccine prime-inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses
    • Heterologous DNA prime-inactivated flu vaccine boost is more effective than the homologous prime-boost with inactivated flu vaccine in eliciting protective antibody responses in an animal model naïve to flu antigen, pointing to new vaccination strategies against influenza viruses that may cause pandemic flu in the world human populations.
    • Wang S., Parker C., Taaffe J., Solorzano A., Garcia-Sastre A., and Lu S. Heterologous HA DNA vaccine prime-inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses. Vaccine 26 (2008) 3626-3633. Heterologous DNA prime-inactivated flu vaccine boost is more effective than the homologous prime-boost with inactivated flu vaccine in eliciting protective antibody responses in an animal model naïve to flu antigen, pointing to new vaccination strategies against influenza viruses that may cause pandemic flu in the world human populations.
    • (2008) Vaccine , vol.26 , pp. 3626-3633
    • Wang, S.1    Parker, C.2    Taaffe, J.3    Solorzano, A.4    Garcia-Sastre, A.5    Lu, S.6
  • 35
    • 33847075902 scopus 로고    scopus 로고
    • In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer
    • Garcia-Hernandez Mde L., Gray A., Hubby B., and Kast W.M. In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer. Cancer Res 67 (2007) 1344-1351
    • (2007) Cancer Res , vol.67 , pp. 1344-1351
    • Garcia-Hernandez Mde, L.1    Gray, A.2    Hubby, B.3    Kast, W.M.4
  • 36
    • 21544454118 scopus 로고    scopus 로고
    • The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis
    • Skinner M.A., Wedlock D.N., de Lisle G.W., Cooke M.M., Tascon R.E., Ferraz J.C., Lowrie D.B., Vordermeier H.M., Hewinson R.G., and Buddle B.M. The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis. Infect Immun 73 (2005) 4441-4444
    • (2005) Infect Immun , vol.73 , pp. 4441-4444
    • Skinner, M.A.1    Wedlock, D.N.2    de Lisle, G.W.3    Cooke, M.M.4    Tascon, R.E.5    Ferraz, J.C.6    Lowrie, D.B.7    Vordermeier, H.M.8    Hewinson, R.G.9    Buddle, B.M.10
  • 37
    • 0142231018 scopus 로고    scopus 로고
    • Efficient induction of T helper 1 CD4+ T-cell responses to hepatitis C virus core and E2 by a DNA prime-adenovirus boost
    • The order of prime-boost with DNA and adenovirus vector vaccines is important for the induction of cell-mediated immune responses against HCV E2 antigen.
    • Park S.H., Yang S.H., Lee C.G., Youn J.W., Chang J., and Sung Y.C. Efficient induction of T helper 1 CD4+ T-cell responses to hepatitis C virus core and E2 by a DNA prime-adenovirus boost. Vaccine 21 (2003) 4555-4564. The order of prime-boost with DNA and adenovirus vector vaccines is important for the induction of cell-mediated immune responses against HCV E2 antigen.
    • (2003) Vaccine , vol.21 , pp. 4555-4564
    • Park, S.H.1    Yang, S.H.2    Lee, C.G.3    Youn, J.W.4    Chang, J.5    Sung, Y.C.6
  • 38
    • 47749129289 scopus 로고    scopus 로고
    • Improved induction of antibodies against key neutralizing epitopes by human immunodeficiency virus type 1 gp120 DNA prime-protein boost vaccination compared to gp120 protein-only vaccination
    • Including a DNA priming protein boost immunization was able to elicit conformation sensitive antibody responses when compared to protein alone HIV-1 Env vaccine.
    • Vaine M., Wang S., Crooks E.T., Jiang P., Montefiori D.C., Binley J., and Lu S. Improved induction of antibodies against key neutralizing epitopes by human immunodeficiency virus type 1 gp120 DNA prime-protein boost vaccination compared to gp120 protein-only vaccination. J Virol 82 (2008) 7369-7378. Including a DNA priming protein boost immunization was able to elicit conformation sensitive antibody responses when compared to protein alone HIV-1 Env vaccine.
    • (2008) J Virol , vol.82 , pp. 7369-7378
    • Vaine, M.1    Wang, S.2    Crooks, E.T.3    Jiang, P.4    Montefiori, D.C.5    Binley, J.6    Lu, S.7
  • 39
    • 20744438004 scopus 로고    scopus 로고
    • Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins
    • Otten G.R., Schaefer M., Doe B., Liu H., Srivastava I., Megede J., Kazzaz J., Lian Y., Singh M., Ugozzoli M., et al. Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins. J Virol 79 (2005) 8189-8200
    • (2005) J Virol , vol.79 , pp. 8189-8200
    • Otten, G.R.1    Schaefer, M.2    Doe, B.3    Liu, H.4    Srivastava, I.5    Megede, J.6    Kazzaz, J.7    Lian, Y.8    Singh, M.9    Ugozzoli, M.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.